RxDoctor Payments Data

Ramakrishna Veluri, MD

Psychiatry · Fort Worth, TXNPI 1033525050

Payments from drug & device makers

$193in general payments, 2019–2025

Across 9 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$38
  • Teva Pharmaceuticals USA, Inc.$35
  • Johnson & Johnson$26
  • Luye Pharma (USA) Ltd.$24
  • Supernus Pharmaceuticals, Inc.$22
  • Sunovion Pharmaceuticals Inc.$19
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$193100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$193 in reported general payments places this provider in the 45th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$52,785
Medicare patients
74
Services billed
813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate20$72,043
Divalproex Sodium62$1,930
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl18$1,872
Paliperidone ErPaliperidone18$1,653
Clozapine34$1,379
Haloperidol41$1,291
Olanzapine OdtOlanzapine49$1,233
Fluphenazine Decanoate14$893
Quetiapine Fumarate55$731
Divalproex Sodium ErDivalproex Sodium17$687
Olanzapine38$650
Valproic AcidValproic Acid (As Sodium Salt)29$611
Benztropine Mesylate46$539
Hydroxyzine Pamoate33$446
Oxcarbazepine16$389

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$26$72,04320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →